Form 8-K - Current report:
SEC Accession No. 0001193125-26-127253
Filing Date
2026-03-27
Accepted
2026-03-27 06:10:14
Documents
9
Period of Report
2026-03-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K mreo-20260326.htm   iXBRL 8-K 52650
  Complete submission text file 0001193125-26-127253.txt   209497

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mreo-20260326.xsd EX-101.SCH 58314
13 EXTRACTED XBRL INSTANCE DOCUMENT mreo-20260326_htm.xml XML 6519
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON United Kingdom W1G 0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON United Kingdom W1G 0QF 4403330237300
Mereo BioPharma Group plc (Filer) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38452 | Film No.: 26800770
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)